PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio’s Board of Directors. Dr. Gibson ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...

Explore recursive SNARKs and proof composition in blockchain, boosting scalability, efficiency, and secure zero-knowledge verification ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will be featured in HighRes’ Lightning Talk at the NVIDIA GTC AI ...

Abstract: This letter presents a novel method for environmental exploration that takes safety into account in unknown areas by using recursive Gaussian process regression (RGPR). Safety in unknown ...

A Samsung AI researcher in Montreal has created a tiny AI model that punches far above its weight, challenging the industry’s focus on massive scale. Released this week, the 7-million-parameter Tiny ...

Now that you know why the program cannot access the file, it is time to figure out which process has already put a lock on them. The error could appear in any program ...

Cathie Wood's Ark Invest bought shares in Figma, CoreWeave, and Recursion Pharmaceuticals on Friday. Figma stock has fallen 30% this year, but it's been rising in recent days with a strong quarterly ...